RankAlpha logo
Back to Rankings

ANTX

AN2 TherapeuticsA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
ANTX vs peer average
95/100
ANTX vs. peer average (A vs. D)
Grade spread
A 2 · B 1 · D 2 · F 6
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

BRNS is the first available peer comparator.

Low-cap biotech comparator with sentiment driven by trial progress and access to capital, making it directionally relevant for ANTX's speculative setup.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerBRNSBarinthus Biotherapeutics
ANTX
AN2 Therapeutics
BRNS
Barinthus Biotherapeutics
Grade
A
F
Momentum
99
9
Value
41
58
Sentiment
54
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs BRNS

ANTX / BRNS
Grade Position
Above peers
ANTX vs. peer average (A vs. D)
95/100
Momentum
99
ANTX
Value
41
BRNS
Sentiment
54
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ANTX
1
BRNS
BRNS
F
20/100
+4
2
MRKR
MRKR
B
80/100
+1
3
SNTI
SNTI
F
20/100
+4
4
ORMP
Oramed Pharmaceuticals Inc Common
F
20/100
+4
5
MSLE
Satellos Bioscience Inc Common
F
20/100
+4
BRNS is the first peer returned for this comparison set.